Nepal, facing vaccine shortage, gets 1.5 million J&J doses from US

Nepal on Monday received over 1.5 million doses of Johnson & Johnson vaccine from the US at the time when the country is facing a severe shortage of the jabs

Johnson & Johnson's Vaccine, J&J, Coronavirus vaccine
Photo: Shutterstock
Press Trust of India Kathmandu
2 min read Last Updated : Jul 12 2021 | 4:04 PM IST

Nepal on Monday received over 1.5 million doses of Johnson & Johnson vaccine from the US at the time when the country is facing a severe shortage of the jabs.

This is the first consignment of the single-shot vaccine Nepal has received. The US provided 1,534,850 doses to Nepal through the COVAX scheme, the global COVID vaccine equity scheme.

US Ambassador Randy Berry handed over the vaccines to Health Minister Krishna Gopal Shrestha on Monday.

Today we're giving Nepal enough #JNJ COVID19 vaccines via #COVAX to fully vaccinate 1.5 million people, Berry wrote on Twitter after handing over the vaccine to Nepal.

I'm proud that the US is the largest single-country donor of #COVID19 assistance to Nepal. This gift, on behalf of the American people, has the singular goal of saving lives, Berry added.

Prime Minister K P Sharma Oli conveyed sincere gratitude to the Government and the people of Nepal to the US Government for providing the generous support of vaccines.

Health Minister Shrestha said on Monday that the American vaccine will be given to people aged 50 to 54, the Kathmandu Post reported.

The arrival of the Johnson & Johnson vaccine will complement Nepal's vaccination drive amid the second wave of the COVID-19 pandemic, according to a press release issued by the Ministry of Foreign Affairs.

It is a big respite for Nepal, which is struggling to secure enough doses to inoculate its populationaround 72 per cent of the total.

Nepal started its vaccination drive with the 1 million doses of Covishield, the AstraZeneca type vaccine manufactured by the Serum Institute of India, which were gifted to Nepal by the Indian government.

Of the 2 million doses Nepal bought from the Serum Institute, only 1 million doses were shipped, the report added.

The Johnson & Johnson doses arrived days after 8 million doses of Vero Cell, a double-shot vaccine manufactured and developed by Sinopharm, were brought in from China, the report said.

The consignment was part of 4 million doses Nepal has bought from China. China has already provided 1.8 million doses of Vero Cell under grant assistance, the report added.

Nepal's coronavirus caseload reached 699,088 with the detection of 1,831 new cases in the last 24 hours, the ministry said on Sunday. Of the total cases, 619,894 people have recovered so far.

The countrywide COVID-19 death toll increased to 9,382 with 20 more fatalities.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jul 12 2021 | 4:03 PM IST

Next Story